These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 9387402)

  • 1. Study on inhibition of pancreatic exocrine secretion by somatostatin in rats.
    He X; Nelson MT; Debas H
    Chin Med Sci J; 1996 Sep; 11(3):166-9. PubMed ID: 9387402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of intrapancreatic neuronal activation on cholecystokinin-induced exocrine secretion of isolated perfused rat pancreas.
    Park HS; Park IS; Lee YL; Kwon HY; Park HJ
    Pflugers Arch; 1999 Mar; 437(4):511-6. PubMed ID: 10089562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of pancreatic exocrine secretion in the rat by calcitonin gene-related peptide: involvement of circulating somatostatin.
    Mulholland MW; Garcia R; Garcia I; Taborsky GJ; Helton S
    Endocrinology; 1989 Apr; 124(4):1849-56. PubMed ID: 2466638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microinjection of exogenous somatostatin in the dorsal vagal complex inhibits pancreatic secretion via somatostatin receptor-2 in rats.
    Liao Z; Li ZS; Lu Y; Wang WZ
    Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G746-52. PubMed ID: 17138968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cholecystokinin inhibits gastric acid secretion through type "A" cholecystokinin receptors and somatostatin in rats.
    Lloyd KC; Raybould HE; Walsh JH
    Am J Physiol; 1992 Sep; 263(3 Pt 1):G287-92. PubMed ID: 1357976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exocrine effects of the CCK antagonist L-364,718 in canine pancreatic autografts.
    Garvin PJ; Niehoff ML; Burton FR; Dysarz FA; Meadow R; Solomon H
    J Surg Res; 1996 Feb; 61(1):256-9. PubMed ID: 8769975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrapancreatic cholecystokinin mediates vagally stimulated exocrine secretion from the rat pancreas.
    He X; Nelson MT; Debas HT
    Chin Med Sci J; 1996 Mar; 11(1):32-5. PubMed ID: 9206116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rat exocrine pancreatic secretion by vagal stimulation occurs via multiple mediators.
    He X; Nelson MT; Debas HT
    Chin Med Sci J; 1996 Jun; 11(2):73-7. PubMed ID: 9387412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Somatostatin inhibits pancreatic exocrine secretion via a neural mechanism.
    Mulvihill SJ; Bunnett NW; Goto Y; Debas HT
    Metabolism; 1990 Sep; 39(9 Suppl 2):143-8. PubMed ID: 1698248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of gamma-aminobutyric acid on secretagogue-induced exocrine secretion of isolated, perfused rat pancreas.
    Park HS; Park HJ
    Am J Physiol Gastrointest Liver Physiol; 2000 Oct; 279(4):G677-82. PubMed ID: 11005753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of GABA on pancreatic exocrine secretion of rats.
    Park HS; Park HJ
    J Korean Med Sci; 2000 Aug; 15 Suppl(Suppl):S24-6. PubMed ID: 10981502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective release of somatostatin by calcitonin gene-related peptide and influence on pancreatic secretion.
    Debas HT; Nelson MT; Bunnett NW; Mulvihill SJ
    Ann N Y Acad Sci; 1992 Jun; 657():289-98. PubMed ID: 1379016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term blockade of cholecystokinin (CCK): effects of L 364,718 (a CCK receptor antagonist) on pancreatic enzyme storage and secretion.
    Rodriguez AI; Manso MA; Garcia-Montero AC; Orfao A; de Dios I
    Pancreas; 1997 Oct; 15(3):314-22. PubMed ID: 9336798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Secretory response of cultured acinar cells of rat pancreas to cholecystokinin.
    Kim H; Kim KH
    Yonsei Med J; 1996 Dec; 37(6):405-11. PubMed ID: 9048493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatostatin inhibits CCK release by inhibiting secretion and action of CCK-releasing peptide.
    Herzig KH; Louie DS; Owyang C
    Am J Physiol; 1994 Jun; 266(6 Pt 1):G1156-61. PubMed ID: 7517637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L364718, a new CCK antagonist, inhibits biological actions of CCK in conscious dogs.
    Hosotani R; Chowdhury P; McKay D; Rayford PL
    Peptides; 1987; 8(6):1061-4. PubMed ID: 3441445
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of loxiglumide on pancreatic exocrine secretion stimulated by cholecystokinin-8 in conscious dogs.
    Ninomiya K; Saito T; Wakatsuki K; Saeki M; Kato T; Kasai H; Kimura K; Fujii M
    Arzneimittelforschung; 1998 Jan; 48(1):52-4. PubMed ID: 9522032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of neural blockade on somatostatin-induced inhibition of exocrine pancreatic secretion.
    Schönfeld JV; Müller MK; Demirtas B; Soukup J; Rünzi M; Goebell H
    Digestion; 1989; 43(1-2):81-6. PubMed ID: 2572497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of growth hormone-release inhibiting hormone on hormones stimulating exocrine pancreatic secretion.
    Konturek SJ; Tasler J; Obtulowicz W; Coy DH; Schally AV
    J Clin Invest; 1976 Jul; 58(1):1-6. PubMed ID: 932201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.
    Lotti VJ; Pendleton RG; Gould RJ; Hanson HM; Chang RS; Clineschmidt BV
    J Pharmacol Exp Ther; 1987 Apr; 241(1):103-9. PubMed ID: 2437282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.